STOCK TITAN

Agilent Technologies Inc. - A STOCK NEWS

Welcome to our dedicated news page for Agilent Technologies (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Agilent Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Agilent Technologies's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.77%
Tags
none
Rhea-AI Summary
Agilent Technologies introduces new liquid chromatography mass spectrometry systems and software
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.11%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.11%
Tags
none
-
Rhea-AI Summary
Agilent Technologies announced new mass spectrometry solutions at the ASMS Conference. The company aims to make mass spectrometry more accessible by developing self-aware and intelligent instruments. New products include LC/TQ and LC/Q-TOF systems with intelligence features, an HPLC autosampler, and software enhancements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.95%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
conferences
-
Rhea-AI Summary
Agilent Technologies plans to appeal the U.S. Patent and Trademarks Office's decision regarding the Inter Partes review of its patents related to CRISPR guide RNA. The company disagrees with the opinion of unpatentability and believes in the innovative contributions made by its scientists. The decision does not affect Agilent's ability to make or sell chemically modified gRNA guides.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.21%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.17%
Tags
dividends
Agilent Technologies Inc.

NYSE:A

A Rankings

A Stock Data

40.09B
291.94M
0.28%
93.13%
1.35%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
Santa Clara

About A

analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.